MPLT – maplight therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Maplight Therapeutics (MPLT) is now covered by Needham & Company LLC. They set a "buy" rating and a $37.00 price target on the stock.
Maplight Therapeutics (MPLT) is now covered by TD Cowen. They set a "buy" rating on the stock.
MapLight Therapeutics, Inc. GAAP EPS of -$2.47 [Seeking Alpha]
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Maplight Therapeutics (MPLT) was downgraded by Wall Street Zen from "
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: GILLIS JONATHAN
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Setia Vishwas
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Kreitzer Anatol
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Foff Erin Pennock
Form 4 MapLight Therapeutics, For: Apr 15 Filed by: Lillie James Woodruff
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.